histamine has been researched along with MS (Multiple Sclerosis) in 28 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Histamine has a long history of therapeutic use in many diseases, including multiple sclerosis (MS)." | 9.09 | Transdermal histamine in multiple sclerosis: part one -- clinical experience. ( Ballasiotes, G; DeLack, E; Gillson, G; Wright, JV, 1999) |
| "This paper is the companion to an earlier publication, which discussed preliminary results of transdermal histamine use for ameliorating symptoms of both relapsing-remitting and progressive multiple sclerosis (MS)." | 8.80 | Transdermal histamine in multiple sclerosis, part two: a proposed theoretical basis for its use. ( Ballasiotes, G; DeLack, E; Gillson, G; Wright, JV, 2000) |
| "The authors investigated the amount of blood histamine in 92 patients with multiple sclerosis depending on the length of the disease and its clinical form." | 7.68 | [The characteristics of the blood histamine indices and of the pathomorphological changes in the gastric mucosa of patients with multiple sclerosis]. ( Iarosh, OO; Kanevs'ka, SA, 1992) |
| "The CSF of twenty-six patients with multiple sclerosis (MS) and of twelve control persons was analysed for histamine and histamine-N-methyltransferase (HMT) activity." | 7.66 | Histamine and histamine-N-methyltransferase in the CSF of patients with multiple sclerosis. ( Kilpeläinen, H; Riekkinen, P; Tuomisto, L, 1983) |
| "Histamine was administered intravenously or by iontophoresis to 19 patients with clearly established diagnosis of multiple sclerosis." | 7.63 | Histamine treatment of multiple sclerosis. ( SCHALLER, WF; SMITH, JK, 1953) |
| "Multiple sclerosis is an autoimmune disease with a strong neuroinflammatory component that contributes to severe demyelination, neurodegeneration and lesions formation in white and grey matter of the spinal cord and brain." | 5.72 | Repurposing Histaminergic Drugs in Multiple Sclerosis. ( Amadio, S; Conte, F; Esposito, G; Fiscon, G; Paci, P; Volonté, C, 2022) |
| "Histamine has a long history of therapeutic use in many diseases, including multiple sclerosis (MS)." | 5.09 | Transdermal histamine in multiple sclerosis: part one -- clinical experience. ( Ballasiotes, G; DeLack, E; Gillson, G; Wright, JV, 1999) |
| "This paper is the companion to an earlier publication, which discussed preliminary results of transdermal histamine use for ameliorating symptoms of both relapsing-remitting and progressive multiple sclerosis (MS)." | 4.80 | Transdermal histamine in multiple sclerosis, part two: a proposed theoretical basis for its use. ( Ballasiotes, G; DeLack, E; Gillson, G; Wright, JV, 2000) |
| "Hydrogen-rich water has a significant protective effect on OGD/R-causing HT22 cell injury, and the mechanism may be related to the inhibition of autophagy." | 4.40 | Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19. ( , 2023) |
| "Histamine is best known for its role in allergies, but it could also be involved in autoimmune diseases such as multiple sclerosis." | 4.02 | Conditional Deletions of ( Dumas, A; Mdzomba, JB; Morin, F; Pernet, V; Singh, N; Vallières, L, 2021) |
| "Histamine (HA) is a key regulator of experimental allergic encephalomyelitis (EAE), the autoimmune model of multiple sclerosis." | 3.79 | Systemic lack of canonical histamine receptor signaling results in increased resistance to autoimmune encephalomyelitis. ( Case, LK; del Rio, R; Noubade, R; Saligrama, N; Teuscher, C, 2013) |
| "Mast cells may invade the brain as a consequence of a childhood infection or predisposition, and it is proposed that multiple sclerosis arises due to the effect of various mediators (histamine and protease) released from the perivascular mast cells after stimulation by some diet factor." | 3.69 | The role of mast cells and diet in the onset and maintenance of multiple sclerosis: a hypothesis. ( Krüger, PG; Nyland, HI, 1995) |
| "The authors investigated the amount of blood histamine in 92 patients with multiple sclerosis depending on the length of the disease and its clinical form." | 3.68 | [The characteristics of the blood histamine indices and of the pathomorphological changes in the gastric mucosa of patients with multiple sclerosis]. ( Iarosh, OO; Kanevs'ka, SA, 1992) |
| "Using oligodendrocytes from primary brain cultures as targets in an antibody-dependent cellular cytotoxicity (ADCC) assay, we have examined the effects of insulin and histamine on killer cells in multiple sclerosis (MS) and other neurological disease (OND) controls compared to normal healthy controls." | 3.67 | Regulation of antibody-dependent cellular cytotoxicity in multiple sclerosis by central nervous system hormones. ( Merrill, JE; Mohlstrom, C, 1987) |
| "The CSF of twenty-six patients with multiple sclerosis (MS) and of twelve control persons was analysed for histamine and histamine-N-methyltransferase (HMT) activity." | 3.66 | Histamine and histamine-N-methyltransferase in the CSF of patients with multiple sclerosis. ( Kilpeläinen, H; Riekkinen, P; Tuomisto, L, 1983) |
| "Histamine was administered intravenously or by iontophoresis to 19 patients with clearly established diagnosis of multiple sclerosis." | 3.63 | Histamine treatment of multiple sclerosis. ( SCHALLER, WF; SMITH, JK, 1953) |
| "Multiple sclerosis is an autoimmune disease with a strong neuroinflammatory component that contributes to severe demyelination, neurodegeneration and lesions formation in white and grey matter of the spinal cord and brain." | 1.72 | Repurposing Histaminergic Drugs in Multiple Sclerosis. ( Amadio, S; Conte, F; Esposito, G; Fiscon, G; Paci, P; Volonté, C, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (42.86) | 18.7374 |
| 1990's | 5 (17.86) | 18.2507 |
| 2000's | 1 (3.57) | 29.6817 |
| 2010's | 6 (21.43) | 24.3611 |
| 2020's | 4 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Amadio, S | 2 |
| Conte, F | 1 |
| Esposito, G | 1 |
| Fiscon, G | 1 |
| Paci, P | 1 |
| Volonté, C | 2 |
| Morin, F | 1 |
| Singh, N | 1 |
| Mdzomba, JB | 1 |
| Dumas, A | 1 |
| Pernet, V | 1 |
| Vallières, L | 1 |
| Apolloni, S | 1 |
| Saligrama, N | 1 |
| Case, LK | 1 |
| del Rio, R | 1 |
| Noubade, R | 1 |
| Teuscher, C | 1 |
| Sun, WY | 1 |
| Dimasi, DP | 1 |
| Pitman, MR | 1 |
| Zhuang, Y | 1 |
| Heddle, R | 1 |
| Pitson, SM | 1 |
| Grimbaldeston, MA | 1 |
| Bonder, CS | 1 |
| Jadidi-Niaragh, F | 1 |
| Mirshafiey, A | 1 |
| Bassetti, CL | 1 |
| Baumann, CR | 1 |
| Dauvilliers, Y | 1 |
| Croyal, M | 1 |
| Robert, P | 1 |
| Schwartz, JC | 1 |
| Lapilla, M | 1 |
| Gallo, B | 1 |
| Martinello, M | 1 |
| Procaccini, C | 1 |
| Costanza, M | 1 |
| Musio, S | 1 |
| Rossi, B | 1 |
| Angiari, S | 1 |
| Farina, C | 1 |
| Steinman, L | 1 |
| Matarese, G | 1 |
| Constantin, G | 1 |
| Pedotti, R | 1 |
| Tiligada, E | 1 |
| Kyriakidis, K | 1 |
| Chazot, PL | 1 |
| Passani, MB | 1 |
| SMITH, JK | 1 |
| SCHALLER, WF | 1 |
| HERRAIZ BALLESTERO, L | 1 |
| BERNSTEIN, C | 1 |
| KLOTZ, SD | 1 |
| SZIRMAI, E | 1 |
| STARY, O | 1 |
| VYMAZAL, J | 1 |
| PROCHAZKOVA, Z | 1 |
| RIEDER, HP | 1 |
| HONEGGER, CG | 1 |
| KELLER, R | 1 |
| ABRAMSON, HA | 1 |
| Tuomisto, L | 1 |
| Kilpeläinen, H | 1 |
| Riekkinen, P | 1 |
| Krüger, PG | 1 |
| Nyland, HI | 1 |
| Rozniecki, JJ | 1 |
| Hauser, SL | 1 |
| Stein, M | 1 |
| Lincoln, R | 1 |
| Theoharides, TC | 1 |
| Gillson, G | 2 |
| Wright, JV | 2 |
| DeLack, E | 2 |
| Ballasiotes, G | 2 |
| Iarosh, OO | 1 |
| Kanevs'ka, SA | 1 |
| Saito, H | 1 |
| Kobayashi, K | 1 |
| Mochizuki, H | 1 |
| Ishii, T | 1 |
| Merrill, JE | 1 |
| Mohlstrom, C | 1 |
| Markov, DA | 1 |
| Leonovich, AL | 1 |
| Starostenko, LI | 1 |
| Bartko, D | 1 |
| Böhmová, L | 1 |
| Molnár, G | 1 |
| Moldován, J | 1 |
3 reviews available for histamine and MS (Multiple Sclerosis)
| Article | Year |
|---|---|
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosp | 2023 |
Histamine pharmacology and new CNS drug targets.
Topics: Animals; Brain; Brain Chemistry; Central Nervous System Agents; Cognition Disorders; Histamine; Hist | 2011 |
Transdermal histamine in multiple sclerosis, part two: a proposed theoretical basis for its use.
Topics: Administration, Cutaneous; Histamine; Humans; Multiple Sclerosis | 2000 |
2 trials available for histamine and MS (Multiple Sclerosis)
| Article | Year |
|---|---|
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Actin Cytoskeleton; Actins; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenosine Triphosp | 2023 |
Transdermal histamine in multiple sclerosis: part one -- clinical experience.
Topics: Administration, Cutaneous; Adult; Aged; Female; Histamine; Humans; Male; Middle Aged; Multiple Scler | 1999 |
24 other studies available for histamine and MS (Multiple Sclerosis)
| Article | Year |
|---|---|
Repurposing Histaminergic Drugs in Multiple Sclerosis.
Topics: Drug Repositioning; Histamine; Histamine Agents; Humans; Multiple Sclerosis; Receptors, Histamine H4 | 2022 |
Conditional Deletions of
Topics: Anaphylaxis; Animals; Cells, Cultured; Circadian Rhythm; Disease Models, Animal; Encephalomyelitis, | 2021 |
The Histamine and Multiple Sclerosis Alliance: Pleiotropic Actions and Functional Validation.
Topics: Animals; Cell Differentiation; Encephalomyelitis, Autoimmune, Experimental; Histamine; Immune System | 2022 |
Systemic lack of canonical histamine receptor signaling results in increased resistance to autoimmune encephalomyelitis.
Topics: Animals; Antigen-Presenting Cells; Blood-Brain Barrier; CD4-Positive T-Lymphocytes; Cell Differentia | 2013 |
Topical Application of Fingolimod Perturbs Cutaneous Inflammation.
Topics: Administration, Topical; Animals; Capillary Permeability; Cell Movement; Cells, Cultured; Cytokines; | 2016 |
Histamine and histamine receptors in pathogenesis and treatment of multiple sclerosis.
Topics: Animals; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Histamine; Histamine A | 2010 |
Cerebrospinal fluid histamine levels are decreased in patients with narcolepsy and excessive daytime sleepiness of other origin.
Topics: Adult; Aged; Disorders of Excessive Somnolence; Female; Histamine; Humans; Idiopathic Hypersomnia; M | 2010 |
Histamine regulates autoreactive T cell activation and adhesiveness in inflamed brain microcirculation.
Topics: Animals; Blood-Brain Barrier; Brain; Cell Adhesion; Cell Proliferation; Cells, Cultured; Chemotaxis, | 2011 |
Histamine treatment of multiple sclerosis.
Topics: Central Nervous System; Death; Histamine; Humans; Iontophoresis; Multiple Sclerosis | 1953 |
[Treatment of multiple sclerosis by specific desensitization; histamine, ACTH and cortisone].
Topics: Adrenocorticotropic Hormone; Biological Phenomena; Cortisone; Desensitization, Immunologic; Histamin | 1953 |
Clinical observations on use of histamine in medical practice.
Topics: Histamine; Hypersensitivity; Immune System Diseases; Multiple Sclerosis; Psychotherapy, Multiple | 1955 |
[On the drug preparation H.A.H. (Heacrin) (useful for the treatment of peripheral blood circulation disorders, muscular or nerve paralysis, rheumatic changes, phenomena of aging, multiple sclerosis)].
Topics: Anticoagulants; Blood Proteins; Drug Compounding; Heparin; Histamine; Humans; Multiple Sclerosis; Pa | 1960 |
[Study of histaminopexy in disseminated sclerosis].
Topics: Histamine; Humans; Multiple Sclerosis | 1961 |
[HISTAMINE IN THE BLOOD AND URINE OF MULTIPLE SCLEROSIS PATIENTS].
Topics: Blood Chemical Analysis; Body Fluids; Histamine; Multiple Sclerosis; Urine | 1963 |
Histamine iontophoresis in the therapy of multiple sclerosis.
Topics: Histamine; Ion Exchange; Iontophoresis; Multiple Sclerosis; Sclerosis | 1949 |
Histamine and histamine-N-methyltransferase in the CSF of patients with multiple sclerosis.
Topics: Adolescent; Adult; Histamine; Histamine N-Methyltransferase; Humans; Methyltransferases; Middle Aged | 1983 |
The role of mast cells and diet in the onset and maintenance of multiple sclerosis: a hypothesis.
Topics: Animals; Climate; Diet; Endopeptidases; Histamine; Humans; Mast Cells; Multiple Sclerosis; Philosoph | 1995 |
Elevated mast cell tryptase in cerebrospinal fluid of multiple sclerosis patients.
Topics: Adult; Chymases; Female; Histamine; Humans; Male; Mast Cells; Methylhistamines; Middle Aged; Multipl | 1995 |
[The characteristics of the blood histamine indices and of the pathomorphological changes in the gastric mucosa of patients with multiple sclerosis].
Topics: Adult; Biopsy; Chronic Disease; Female; Gastric Mucosa; Histamine; Humans; Male; Middle Aged; Multip | 1992 |
Axonal degeneration of the peripheral nerves and postganglionic anhidrosis in a patient with multiple sclerosis.
Topics: Adult; Autonomic Fibers, Postganglionic; Axons; Electrophysiology; Female; Histamine; Humans; Hypohi | 1990 |
Regulation of antibody-dependent cellular cytotoxicity in multiple sclerosis by central nervous system hormones.
Topics: Antibody-Dependent Cell Cytotoxicity; Central Nervous System; Cimetidine; Histamine; Humans; Insulin | 1987 |
[Search for a differentiated pathogenetic therapy and the prevention of disseminated sclerosis].
Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adrenal Cortex Function Tests; Antigen-Antibody Reaction | 1974 |
[Experiences in prednisone treatment of multiple sclerosis as compared to other therapeutic methods (preliminary report)].
Topics: Adolescent; Adult; Ethyl Biscoumacetate; Female; Histamine; Humans; Iontophoresis; Male; Middle Aged | 1965 |
Histamine content of the cerebrospinal fluid in multiple sclerosis. A preliminary communication.
Topics: Histamine; Humans; Multiple Sclerosis | 1966 |